Mark J. Adler, M.D.
Director at Forian Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Board Certified Medical Oncologist
American Board of Internal MedicineSep, 1989- Nov, 2024 -
American Board of Internal Medicine
American Board of Internal MedicineJan, 1986- Nov, 2024
Experience
-
Forian Inc.
-
United States
-
Information Technology & Services
-
1 - 100 Employee
-
Director
-
Jan 2020 - Present
application of informatics to Big Data application of informatics to Big Data
-
-
-
-
Clinical and Molecular Oncologist (Diplomat NIH Physician-Scientist Award)
-
Jan 2014 - Present
-
-
Molecular Oncologist
-
Jan 1990 - Present
-
-
-
San Diego Cancer Research Institute 501c3
-
Greater San Diego Area
-
Director Genomic Oncology
-
2003 - Present
Studies on the genetic basis of cancer and early detection tests Studies on the genetic basis of cancer and early detection tests
-
-
-
SAN DIEGO CANCER RESEARCH INSTITUTE
-
United States
-
Non-profit Organizations
-
Institute Director
-
Jun 2004 - Present
-
-
-
Biological Dynamics
-
Greater San Diego Area
-
CHAIR SCIENTIFIC ADVISORY BOARD
-
Jan 2010 - Present
Application of novel technology to detect circulating cell-free tumor DNA as means of monitoring cancer Application of novel technology to detect circulating cell-free tumor DNA as means of monitoring cancer
-
-
-
WebMD
-
Technology, Information and Internet
-
700 & Above Employee
-
Director WebMD
-
1998 - 2017
Director on Board of WebMD and of predecessor companies including Director CareInsite (CARI: Nasdaq), Director HLTH (HLTH; Nasdaq), DirectorEMDEON (Nasdaq), Director SYNETIC (Nasdaq), Director Medical Manager (Nasdaq) Director on Board of WebMD and of predecessor companies including Director CareInsite (CARI: Nasdaq), Director HLTH (HLTH; Nasdaq), DirectorEMDEON (Nasdaq), Director SYNETIC (Nasdaq), Director Medical Manager (Nasdaq)
-
-
-
Genotyping-Autogenomics
-
Carlsbad, California, United States
-
Scientific Advisory Board
-
Jan 2007 - May 2014
translational oncology using molecular genomic tests development test pan-cancer screen general population advisory board Chair and member Board of Director several public companies translational oncology using molecular genomic tests development test pan-cancer screen general population advisory board Chair and member Board of Director several public companies
-
-
-
UC San Diego Health
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Director Strategic Development
-
Feb 2011 - Feb 2014
-
-
Clinical Adjunct Associate Professor
-
Jun 1987 - Feb 2014
Co-Founder and former CEO SDCC (Now UC San Diego Cancer Centers)
-
-
-
UCSD
-
Research Services
-
500 - 600 Employee
-
Molecular Biology of Cancer (diplomat NIH Physician Scientist Award)
-
Jan 1987 - Feb 2014
Studies molecular intereraction between oncogenes and in vitro cellular senescence Studies molecular intereraction between oncogenes and in vitro cellular senescence
-
-
-
UC SAN DIEGO HEALTH SYSTEM-ENCINITAS CANCER
-
United States
-
Hospitals and Health Care
-
Co-Founder and former CEO
-
Jun 1993 - Feb 2011
Founder and CEO Founder and CEO
-
-
Education
-
Yale University
B.A., Philosophy -
YALE University Summa Cum Laude
Bachelor of Arts (B.A.), Special Divisional Major: Philosophy and Neurophysiology -
University of Pennsylvania
Doctor of Medicine (M.D.) -
University of California, San Diego
UCSD San Diego Heatlh, Medical Oncology -
WISTAR INSTITUTE
FELLOW, TUMOR IMMUNOLOGY -
NIH PHYSICIAN SCIENTIST AWARDEE
Molecular Biology of Cancer -
University of Pennsylvania
M.D., Research Myelin at CHOP -
University of Pennsylvania
Doctor of Medicine - MD